WallStreetZenWallStreetZen

NASDAQ: CYRX
Cryoport Inc Stock

$16.03-0.20 (-1.23%)
Updated Apr 25, 2024
CYRX Price
$16.03
Fair Value Price
N/A
Market Cap
$785.11M
52 Week Low
$9.00
52 Week High
$24.17
P/E
-7.25x
P/B
1.61x
P/S
3.24x
PEG
N/A
Dividend Yield
N/A
Revenue
$233.26M
Earnings
-$99.59M
Gross Margin
42.6%
Operating Margin
-40.23%
Profit Margin
-46.1%
Debt to Equity
0.96
Operating Cash Flow
-$757k
Beta
1.35
Next Earnings
May 2, 2024
Ex-Dividend
N/A
Next Dividend
N/A

CYRX Overview

Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.

Zen Score

Industry Average (37)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CYRX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CYRX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CYRX is good value based on its book value relative to its share price (1.61x), compared to the US Integrated Freight & Logistics industry average (4.01x)
P/B vs Industry Valuation
CYRX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more CYRX due diligence checks available for Premium users.

Be the first to know about important CYRX news, forecast changes, insider trades & much more!

CYRX News

Valuation

CYRX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-7.25x
Industry
18.43x
Market
40.97x

CYRX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.61x
Industry
4.01x
CYRX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CYRX's financial health

Profit margin

Revenue
$57.3M
Net Income
-$62.4M
Profit Margin
-112.5%
CYRX's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
CYRX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$957.7M
Liabilities
$468.7M
Debt to equity
0.96
CYRX's short-term assets ($535.11M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CYRX's short-term assets ($535.11M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CYRX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CYRX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$2.5M
Investing
-$14.8M
Financing
-$126.0k
CYRX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CYRX vs Logistic Stocks

TickerMarket Cap1d %P/EP/B
CYRX$785.11M-1.23%-7.25x1.61x
PBI$744.95M-0.47%-1.92x-2.02x
FWRD$607.57M-1.12%3.59x0.79x
RLGT$236.49M+2.23%21.00x1.14x
CRGO$132.67M0.00%-1.88x1.84x

Cryoport Stock FAQ

What is Cryoport's quote symbol?

(NASDAQ: CYRX) Cryoport trades on the NASDAQ under the ticker symbol CYRX. Cryoport stock quotes can also be displayed as NASDAQ: CYRX.

If you're new to stock investing, here's how to buy Cryoport stock.

What is the 52 week high and low for Cryoport (NASDAQ: CYRX)?

(NASDAQ: CYRX) Cryoport's 52-week high was $24.17, and its 52-week low was $9.00. It is currently -33.68% from its 52-week high and 78.11% from its 52-week low.

How much is Cryoport stock worth today?

(NASDAQ: CYRX) Cryoport currently has 48,977,476 outstanding shares. With Cryoport stock trading at $16.03 per share, the total value of Cryoport stock (market capitalization) is $785.11M.

Cryoport stock was originally listed at a price of $749.70 in Aug 22, 2005. If you had invested in Cryoport stock at $749.70, your return over the last 18 years would have been -97.86%, for an annualized return of -19.23% (not including any dividends or dividend reinvestments).

How much is Cryoport's stock price per share?

(NASDAQ: CYRX) Cryoport stock price per share is $16.03 today (as of Apr 25, 2024).

What is Cryoport's Market Cap?

(NASDAQ: CYRX) Cryoport's market cap is $785.11M, as of Apr 26, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Cryoport's market cap is calculated by multiplying CYRX's current stock price of $16.03 by CYRX's total outstanding shares of 48,977,476.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.